ExodusPoint Capital Management, LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$33,000
-81.9%
30,397
-55.9%
0.00%
-100.0%
Q2 2021$182,000
+243.4%
68,881
+229.9%
0.00%
+100.0%
Q4 2020$53,000
+96.3%
20,881
+96.5%
0.00%0.0%
Q3 2020$27,000
-76.3%
10,627
-45.8%
0.00%
-80.0%
Q2 2019$114,00019,6000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders